Is Premature Ovarian Failure an Autoimmune Disease?

References

• Aiman J., Smentek C. Premature ovarian failure. Obstet. Gynaecol 1985; 66: 9–14
   PubMed Web of Science ®Google Scholar
• Coulam C. B., Adamson S. C, Annegers J. F. Incidence of premature ovarian failure. Obstet. Gynaecol 1986; 67: 604–606
   PubMed Web of Science ®Google Scholar
• Weetman A. P. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Bailliere's Clin. Endocrinol. Metab 1995; 9: 157–174
   Google Scholar
• Ahonen P., Koskimies S., Lokki M-L., Tiilikainen A., Perheentupa J. The expression of autoimmune polyglandular disease type 1 appears associated with several HLA-A antigens but not with HLA-DR. J. Clin. Endocrinol. Metab 1988; 66: 1151–1157
   Google Scholar
• Neufeld M., Maclaren N. K., Blizzard R. M. Two types of autoimmune Addison's disease associates with different polyglandular autoimmune (PGA) syndromes. Medicine 1981; 60: 355–362
   PubMed Web of Science ®Google Scholar
• Anderson J. R., Goudie R. B., Gray K., Stuart-Smith D. A. Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin. Exp. Immunol 1968; 3: 107–117
   PubMedGoogle Scholar
• Irvine W. J., Barnes E. W. Addison's disease, ovarian failure and hypoparathyroidism. Clin. Endocrinol. Metab 1975; 4: 379–434
   Google Scholar
• Uibo R., Aavik E., Peterson P., Perheentupa J., Aranko S., Pelkonen R., Krohn K. J. E. Autoantibodies to cytochrome P450 enzymes P450scc, P450cl7, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin. Endocrinol. Metab 1994; 78: 323–328
   PubMedGoogle Scholar
• Chen S., Sawicka J., Betterle C, Powell M, Prentice L., Volpato M., Rees Smith B., Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J. Clin. Endocrinol. Metab 1996; 81: 1871–1876
   PubMed Web of Science ®Google Scholar
• Winqvist O., Gustafsson J., Rorsman F., Karlsson F. A., Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest 1993; 92: 2377–2385
   PubMed Web of Science ®Google Scholar
• Alarćon-Segovia D., Ruiz-Argüelles A., Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol. Today 1996; 17: 163–164
   PubMedGoogle Scholar
• McNatty K. P., Short R. V., Barnes E. W., Irvine W. J. The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture. Clin. Exp. Immunol 1975; 22: 378–384
   Google Scholar
• Winqvist O., Gebre-Medhin G., Gustafsson J., Ritzen E. M., Lundkvist O., Karlsson F. A., Kampe O. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J. Clin. Endocrinol. Melab 1995; 80: 1717–1723
   Google Scholar
• Rcbar R. W., Erickson G. F., Yen S. S. C. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil. Steril 1982; 37: 35–41
   Google Scholar
• Alper M. M., Garner P. R. Premature ovarian failure: its relationship to autoimmune disease. Obstet. Gynaecol 1985; 66: 27–30
   PubMed Web of Science ®Google Scholar
• Pekonen F., Siegberg R., Makinen T., Miettinen A., Yli-Korkala O. Immunological disturbances in patients with premature ovarian failure. Clin. Endocrinol 1986; 25: 1–6
   PubMedGoogle Scholar
• Miyake T., Stao Y., Takeuchi S. Implications of circulating autoantibodies and peripheral blood lymphocytes for the genesis of premature ovarian failure. J. Reprod. Immunol 1987; 12: 163–171
   Google Scholar
• Betterle C, Rossi A., Dalla S. Pria, Artifoni A., Pedini B., Gavasso S., Caretto A. Premature ovarian failure: autoimmunity and natural history. Clin. Endocrinol 1993; 39: 35–43
   PubMed Web of Science ®Google Scholar
• Wheatcroft N. J., Toogood A. A., Li T. C, Cooke I. D., Weetman A. P. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin. Exp. Immunol 1994; 96: 122–128
   PubMedGoogle Scholar
• De Kcrdanet M., Lucas J., Lemee F., Lecornu M. Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin. Endocrinol 1994; 41: 673–676
   Google Scholar
• Tung K. S. K., Lu C. Y. Immunologic basis of reproductive failure. Pathology of Reproductive Failure, F. T. Krans, I. Danijanov, N. Kaufman. Williams & Wilkins, Baltimore 1991; 308–333
   Google Scholar
• Lewis J. Eosinophilic perifolliculitis: a variant of autoimmune oophoritis?. Int. J. Gynaecol. Pathol 1993; 12: 360–364
   Google Scholar
• Sotsiou R, Bottazzo G. F., Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin. Exp. Immunol 1980; 39: 97–111
   PubMed Web of Science ®Google Scholar
• Damewood M. D., Zacur H. A., Hoffman G. J., Rock J. A. Circulating anti-ovarian antibodies in premature ovarian failure. Obstet. Gynaecol 1986; 68: 850–854
   PubMed Web of Science ®Google Scholar
• Ho P. C, Tang G. W. K., Lawton J. W. M. Immunologic studies in patients with premature ovarian failure. Obstet. Gynaecol 1988; 71: 622–626
   PubMedGoogle Scholar
• Kirsop R., Brock C. R., Robinson B. G., Barber R. J., Vivian Wells J., Saunders D. M. Detection of anti-ovarian antibodies by indirect immunofluorescence in patients with premature ovarian failure. Reprod. Fertil. Dev 1991; 3: 537–541
   Google Scholar
• Luborsky J. L., Visintin I., Boyers S., Asari T., Caldwell B., De Cherney A. Ovarian antibodies detected by immobilised antigen immunoassay in patients with premature ovarian failure. J. Clin. Endocrinol. Melab 1990; 70: 69–75
   PubMed Web of Science ®Google Scholar
• Moncayo H., Moncayo R., Benz R., Wolf A., Lau-Ritzen C. H. Detection of autoantibodies directed against both the unoccupied lutenizing hormone/ human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J. Clin. Invest 1989; 84: 1857–1865
   PubMedGoogle Scholar
• Moncayo R., Moncayo H., Dapunt O. Immunological risks of IVF. Lancet 1990; 335: 180
   Google Scholar
• Ciauzzi V., Cigorraga S., Escobar M. E., Rivarola M. A., Charreau E. H. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J. Clin. Endocrinol. Melab 1982; 54: 1221–1228
   Google Scholar
• Escobar M. E., Cigorraga S. B., Chiauzzi V. A., Charreau E. H., Rivarola M. A. Development of the gona-dotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms. Acta. Endocrinol 1982; 99: 431–436
   Google Scholar
• van Wiessenbruch M. M., Hoek A., van Vliet-Bleeker I., Schoemaker J., Drexhage H. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome?/. Clin. Endocrinol. Metab 1991; 73: 360–367
   Google Scholar
• Dumont J. E., Roger P. P., Ludgate M. M. Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts and misconceptions. Endocrine. Rev 1987; 8: 448–451
   Google Scholar
• Tang V. W., Faiman C. Premature ovarian failure: a search for circulating factors against gonadotrophin receptors. Am. J. Obstet. Gynaecol 1983; 136: 816–821
   Google Scholar
• Lambert A., Weetman A. P., McLoughlin J., Wardle C, Sunderland J., Wheatcroft N., Anobile C, Robertson W. R. A search for immunoglobulins inhibiting gonadal cell steroidogenesis in premature ovarian failure. Human Reprod 1996; 11: 1871–1876
   Google Scholar
• Anasti J. N., Flack M. R., Froehlich J., Nelson L. M. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J. Clin. Endocrinol. Metab 1995; 80: 824–828
   Google Scholar
• Rabinowe S. L., George K. L., Ravnikar V. A., Dluhy R. G., Dib S. A. Premature menopause: monoclonal antibody defined T lymphocyte abnormalities and anti-ovarian antibodies. Fertil. Steril 1989; 51: 450–454
   PubMed Web of Science ®Google Scholar
• Nelson L. M., Kimzey L. M., Merriam G. R., Fleisher T. A. Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil. Steril 1991; 55: 1082–1087
   Google Scholar
• El Ghazali G. E. B., Paulie S., Andersson G., Hans-Son Y., Holmquist G., Sun J. B., Olsson T., Ekre H. P., Troye-Blomberg M. Number of interleukin-4 and interferon-y secreting human T cells reactive with tetanus toxoid and mycobacterial antigen PPD or phyto-haemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur. J. Immunol 1993; 23: 2740–2745
   Google Scholar
• Hill J. A., Welch W. R., Faris H. M. P., Anderson D. J. Induction of class II major histocompatibility complex in human granulosa cells by interferon-gamma: a potential mechanism contributing to autoimmune ovarian failure. Am. J. Obsiet. Gynaecol 1990; 162: 534–540
   PubMed Web of Science ®Google Scholar
• Walfish P. G., Gottesman I. S., Shewchuk A. B., Bam J., Hase B. S., Farid N. R. Association of premature ovarian failure with HLA antigens. Tissue Antigens 1983; 21: 168–169
   PubMedGoogle Scholar
• Anasti J. N., Adams S., Kimzey L. M., Defensor R. A., Zachary A. A., Nelson L. M. Karyotypically normal spontaneous premature ovarian failure: evaluation of association with the class II major histocompatibility complex. J. Clin. Endocrinol. Metab 1994; 78: 722–723
   Google Scholar
• Jaroudi K. A., Arora M., Sheth K. V., Sieck U. V., Willemsen W. M. Human leukocyte antigen typing and associated abnormalities in premature ovarian failure. Human Reprod 1994; 9: 2006–2009
   Google Scholar
• Rebar R. W., Cedars M. I. Hypergonadotropic forms of amenorrhea in young women. Reprod. Endocrinol 1992; 21: 173–191
   Google Scholar
• Corenblum B., Rowe T., Taylor P. J. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil. Steril 1993; 59: 988–991
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z., Halachmi S., Peretz B. A., Shmuel Z., Golan D., Makler A., Brandes J. M. Premature ovarian failure -the prognostic application of autoimmunity on conception after ovulation induction. Fertil. Steril 1993; 59: 750–755
   PubMed Web of Science ®Google Scholar
• Tung K. S. K. Mechanism of self-tolerance and events leading to autoimmune disease and autoantibody response. Clin. Immunol. Immunopathol 1994; 73: 275–282
   Google Scholar
• Rose N. R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 1993; 14: 426–429
   PubMedGoogle Scholar